Jestin, Matthieu <br/><br/>
Preemptive rituximab prevents long-term relapses in immune-mediated thrombotic thrombocytopenic purpura.  [electronic resource] 

 -  Blood  11 2018 
 - 2143-2153 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1528-0020 
<br/><br/><label>Standard No.: </label>10.1182/blood-2018-04-840090  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ADAMTS13 Protein--chemistry<br/>Adult<br/>Female<br/>Humans<br/>Immunologic Factors--adverse effects<br/>Male<br/>Middle Aged<br/>Prospective Studies<br/>Protein Conformation--drug effects<br/>Purpura, Thrombotic Thrombocytopenic--drug therapy<br/>Rituximab--adverse effects<br/>Secondary Prevention--methods<br/>Treatment Outcome